Epidemiology of Coronavirus Disease 2019 in Mexico: A Report on Age-Sex Variation in the Duration from Symptom Onset to Fatality as an Outcome in Patients
DOI:
https://doi.org/10.17140/ANTPOJ-4-122Keywords:
COVID-19, Infection, Sex difference, Survival, DeathAbstract
Objective
To describe age-sex differences in the duration from symptom onset to fatality as an outcome in coronavirus desease 2019 (COVID-19) patients.
Methods
The Mexican surveillance system database (up to 15th August 2020) of 70,515 death cases (45,053 males, 25,462 females) in COVID-19 was used for analysis. Age groups for pediatric patients were <1, 1-4, 5-9-years and for the adolescent and adult patients, each decade of life constituted an age group.
Results
Proportionally more deaths occurred among male patients (64%). Median duration was eight days from onset of symptoms until death; mean value was approximately 10-days. Distribution by age groups showed females survived lower number of average days after the onset of symptoms. A tendency of rise in the number of days survived has been observed from infancy to adulthood and a subsequent decline after 70-years of age.
Conclusion
Female patients survived relatively lower number of days with infection until death, compared to males.
References
Datta-Banik S. Sexual dimorphism in the susceptibility to infec-tions: “Being a male is a risk factor” for SARS-Cov-2 infection. J Life Science. 2020; 12(1-2): 12-19. doi: 10.31901/24566306.2020/12.1-
253 2. Mendez-Dominguez N, Alvarez-Baeza A, Carrillo G. Demo-graphic and health indicators in correlation to interstate variability of incidence, confirmation, hospitalization, and lethality in Mexi-co: Preliminary analysis from imported and community acquired cases during COVID-19 outbreak. Int J Environ Res Public Health. 2020; 17: 4281. doi: 10.3390/ijerph17124281
World Health Organization (WHO). WHO Coronavirus Dis-ease (COVID-19) Dashboard. 2020. Web site. https://covid19. who.int/. Accessed August 29, 2020.
Covid-19 México. Gobierno Federal de México. Web site. https://coronavirus.gob.mx/datos/. Accessed August 15, 2020.
Carrillo G, Mendez-Dominguez N, Santos-Zaldivar KD, Perez AR, Morales MA, Koh OC, et al. Clinical course and severity out-come indicators among COVID 19 hospitalized patients in relation to comorbidities distribution Mexican cohort. Med Rxiv. 2020; (In Press).Preprint. doi: 10.1101/2020.07.31.20165480
Lewnard JA, Liu VX, Jackson ML, Schmidt MA, Jewell BL, Flores JP, et al. Incidence, clinical outcomes, and transmission dy-namics of severe coronavirus disease 2019 in California and Wash-ington: Prospective cohort study. BMJ. 2020; 369: m1923. doi: 10.1136/bmj.m1923
Dirección General de Epidemiología. Datos Abiertos – Bases históricas: COVID-19: 15 de agosto del 2020. Web site. https:// www.gob.mx/salud/documentos/datos-abiertos-bases-historicas-direccion-general-de-epidemiologia. Accessed August 15, 2020.
Gargaglioni LH, Marques DA. Let's talk about sex in the context of COVID-19. J Appl Physiol. 2020; 128: 1533-1538. doi: 10.1152/ japplphysiol.00335.2020
Tian S, Chang Z, Wang Y, Wu M, Zhang W, Zhou G, et al. Clinical characteristics and reasons for differences in duration from symptom onset to release from quarantine among patients with COVID-19 in Liaocheng, China. Front Med. 2020; 7: 20. doi: Submit your article to this journal | https://openventio.org/submit-manuscript/ 23 Datta-Banik S et al
3389/fmed.2020.00210 10. Nikpouraghdam M, Farahani AJ, Alishiri GH, Heydari S, Ebra-himnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A sin-gle center study. J Clin Virol. 2020; 127: 104378. doi: 10.1016/j. jcv.2020.104378
Heise L, Greene ME, Opper N, Stavropoulou M, Harper C, Nascimento M, et al. Gender inequality and restrictive gender norms: framing the challenges to health. Lancet. 2019; 393(10189): 2440-2454. doi: 10.1016/S0140-6736(19)30652-X
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk fac-tors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81: e16-e25. doi: 10.1016/j. jinf.2020.04.021
Klein SL, Huber S. Sex differences in susceptibility to viral in-fection. In: Klein SL, Roberts C, eds. Sex Hormones and Immunity to Infection. Berlin, Heidelberg: Springer; 2010: 93-122.
Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: When a chromosome makes the difference. Nat Rev Im-munol. 2010;10, 594-604. doi: 10.1038/nri2815
Weckerle CE, Niewold TB. The unexplained female predomi-nance of systemic lupus erythematosus: Clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011; 40(1): 42-49. doi: 10.1007/s12016-009-8192-4
Du RH, Liang LR, Yang CQ, Wang W, Cao T-Z, Li M, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: A prospective cohort study. Eur Resp J. 2020; 55: 2000524. doi: 10.1183/13993003.00524-2020
Zhou F, YuT, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395: 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prev-alence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020; 94: 91-95. doi: 10.1016/j.ijid.2020.03.017
Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P, et al. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr. 2020; 14: 367-382. doi: 10.1016/j.dsx.2020.04.015
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Anthropology is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
